ArticleHuman vaccines & immunotherapeutics2026
Impact of a 21-valent pneumococcal conjugate vaccine on pneumococcal disease incidence among adults 65-84 years of age in Belgium: An epidemiological modeling study.
Yannick Vandenplas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.